Updates

16-17 october 2015 - 1st Serbian Congress on the Menopause. Professor Svetlana Vujovic, IMS Board member, reports:-The 1st Serbian Congress on the Menopause and Involutive Hypoandrogenism was held on October 16th and 17th, at the National Institute in Belgrade, Serbia. There were 350 participants made up of endocrinologists, gynecologists, general practitioners, psychiatrists, nurses and students… Read More

Some cognitive decline, particularly in the domains of executive functions, is common among menopausal women. A new study has examined the effect of the psychostimulant lisdexamfetamine (LDX) on subjective and objective cognitive function among menopausal women who report new-onset executive function complaints [1]. LDX is a very popular medication indicated for the treatment of attention… Read More

1st IMS Webinar entitled "Osteoporosis & Women" is now available on our website. Click here to watch it now.… Read More

Sleep disturbances increase with advancing age in both women and men although inherent gender differences are apparent. Older women take longer to fall asleep, have greater difficulty in staying asleep, have more daytime sleepiness, less stage 1 and stage 2 NREM sleep. Older women are also more likely to develop insomnia, the restless sleep syndrome… Read More

Growing evidence suggests a role of cardiovascular fat (epicardial + paracardial + aortic) in the pathogenesis of coronary heart disease. In order to study the relationship between deposits of cardiovascular fat and the menopause, El Khoudary and colleagues studied 456 women with an average age of 50 years from the SWAN heart cohort. Sex hormone… Read More

Vulvovaginal atrophy (VVA) is a major consequence of menopause and related loss of the estrogenic effect on the vaginal epithelium. For many decades, the ideal therapeutic approach was to use systemic estrogen, which was very effective. Local treatment with vaginal estrogen (creams, tablets, and rings) is effective to the same extent. But, on the other… Read More

Breast cancer can occur in women below 50 years old and represents 25% of the total number of cases. Risk factors and histological characteristics of breast cancer are different in young women compared with older women. There are many publications on the risk of breast cancer and hormone treatment (MHT) in postmenopausal women. However, less… Read More

In contrast to the large body of literature on psychological symptoms during the menopause transition, relatively little is known about positive well-being including happiness, satisfaction with life and self-actualization at this time. Our recent review article 'Positive well-being during the menopausal transition' [1] responded to this issue though synthesizing quantitative work on positive functioning across… Read More

Prevention of osteoporosis-related fractures has been a major preventive goal during the last years and different interventions have been recommended. Järvinen and colleagues have carried out a meta-analysis of 33 randomized controlled trials (RCTs) and have demonstrated that current screening strategies and bisphosphonate treatment are ineffective in preventing hip fractures [1]. The available RCTs are… Read More

Most women experience menopause between the ages of 45 and 55 years. However, 5% of women will go through menopause early, between the ages of 40 and 45 years, and 1% of women become menopausal prematurely, before the age of 40 years [1]. The causes of premature or early menopause are multiple and range from… Read More